Trial · NCT01092403
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Late asthmatic response (LAR) | Day 8 of each treatment period | LAR as measured by the peak drop in FEV1 from 3 to 7 hours post-allergen challenge |
| Primary | Early asthmatic response (EAR) | Day 8 of every treatment period | EAR as measured by the peak drop in FEV1 from 0 to 3 hours post-allergen challenge |
| Primary | Airway hyperresponsiveness | Days -1, 7 and 9 of each treatment period | Difference between methacholine PC20 measured 24 hours following allergen challenge and methacholine PC20 measured 24 hours before allergen challenge |
| Primary | Safety and tolerability | Physical examination: Day 9, vital signs: Days -1, 1, 7, 8 and 9; twelve-lead ECG: Days 1, 7, 8 and 9 , AEs throughout the study, safety laboratory assessments Day 1 and 9 and Chest X-Ray: Day 9 of the final treatment period | |
| Secondary | LAR's FEV1 AUC | Day 8 of every treatment period | From 3 to 7 hours post-allergen challenge |
| Secondary | FEV1 | Day 9 | 24 hours post-allergen challenge |
| Secondary | EAR's FEV1 AUC | Day 8 | From 0 to 3 hours post-allergen challenge |
| Secondary | Change in FEV1 | Days 1, 7, 8 and 9 | Before inhalation of ASM-024 and as soon as possible following inhalation of ASM-024 |
| Secondary | Induced sputum eosinophil count and eosinophil and neutrophil percentages | Days -1, 7 and 9 of every Treatment Period | |
| Secondary | Blood eosinophil count | Days -1 and 9 of every Treatment Period | |
| Secondary | Total and differential WBC count | Days -1 and 9 of every Treatment Period |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01092403/registered